#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

Cerebrovaskulárního

Turoctocog Alfa in Tertiary Prophylaxis of Hemophilia A or Is It Always About Bleeding? Case Studies

19. 8. 2022 Source: Hemophilia with Movement

This case report from our own practice concerns our experience with the treatment of hemophilia A with turoctocog alfa. The intention is, among other things, to compare different outcomes in our two patients regarding their self-assessment of bleeding without objective validation.

nádor výzkum léčby rakoviny

Nearly 20 Years with Bevacizumab Has Brought Hope for Patients and Deeper Understanding of Solid Tumors

Bevacizumab is among the first targeted therapies used in oncology. For many indications where…
19. 8. 2022 Source: Oncological Treatment
Muž_deprese

Lurasidone in Antipsychotic Therapy – A Case Study of a Virtual Patient from the Laurie Project

MUDr. Elis Bartečků, Ph.D., from the Department of Psychiatry at MU LF and FN Brno presented the…
18. 8. 2022 Source: Modern Treatment of Schizophrenia
obezita a deprese

Complex Impacts of Obesity on the Brains of People with Psychiatric Disorders

Obesity in individuals with bipolar disorder or schizophrenia is closely linked not only to higher…
18. 8. 2022 Source: Modern Treatment of Schizophrenia
čas a krev

Time is Blood! Impact of Diagnostic Delays on Prognosis of Patients with Acquired Hemophilia A

The famous slogan of neurologists in connection with strokes – 'Time is brain!' – can be modified…
16. 8. 2022 Source: Hemophilia
depresivní obézní muž

Treatment of Depression with Persistent Severe Insomnia − Interactive Case Study

A 39-year-old patient comes to the psychiatric office due to depressive symptoms with anxiety and…
11. 8. 2022 Source: Depression and Anxiety
krvácení z nosu

Urgent Administration of Romiplostim in Life-Threatening Bleeding Associated with ITP

Recommendations for the care of acute, especially major bleeding in individuals with severe immune…
10. 8. 2022 Source: Immune Thrombocytopenia
medicínská studie 2

Consensus on the Administration of TPO-RA as Second-Line Therapy in ITP

What is the role of thrombopoietin receptor agonists (TPO-RA) in the second line treatment of…
10. 8. 2022 Source: Immune Thrombocytopenia
velkobuněčný difuzní lymfom

Brentuximab vedotin in combination with lenalidomide and rituximab in R/R DLBCL – results from the open part of the ECHELON-3 study

The aim of the open run-in phase of the randomized placebo-controlled phase III ECHELON-3 study,…
10. 8. 2022 Source: Hematologic Malignancies
pacient s klasickým Hodgkinovým lymfomem

6-year data from the ECHELON-1 study: How does combining brentuximab vedotin with chemotherapy affect overall survival of previously untreated cHL patients?

At this year's annual congress of the European Hematology Association (EHA), results from the…
10. 8. 2022 Source: Hematologic Malignancies
1 63 64 65 66 67 163
Filter by speciality
Remove filters

Conferences

News from the world of medicine

25. 9.
XIX. Pediatrický kongres s mezinárodní účastí

All conferences
Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#